IL58526A - 24,24-difluoro-1alpha,25-dihydroxycholecalciferol and pharmaceutical compositions containing it - Google Patents

24,24-difluoro-1alpha,25-dihydroxycholecalciferol and pharmaceutical compositions containing it

Info

Publication number
IL58526A
IL58526A IL58526A IL5852679A IL58526A IL 58526 A IL58526 A IL 58526A IL 58526 A IL58526 A IL 58526A IL 5852679 A IL5852679 A IL 5852679A IL 58526 A IL58526 A IL 58526A
Authority
IL
Israel
Prior art keywords
dihydroxycholecalciferol
1alpha
difluoro
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL58526A
Other languages
English (en)
Other versions
IL58526A0 (en
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of IL58526A0 publication Critical patent/IL58526A0/xx
Publication of IL58526A publication Critical patent/IL58526A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/48Halogenated derivatives
    • C07C35/52Alcohols with a condensed ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14All rings being cycloaliphatic
    • C07C2602/24All rings being cycloaliphatic the ring system containing nine carbon atoms, e.g. perhydroindane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Character Discrimination (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
IL58526A 1979-03-28 1979-10-22 24,24-difluoro-1alpha,25-dihydroxycholecalciferol and pharmaceutical compositions containing it IL58526A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/024,848 US4201881A (en) 1979-03-28 1979-03-28 24,24-Difluoro-1α,25-dihydroxycholecalciferol

Publications (2)

Publication Number Publication Date
IL58526A0 IL58526A0 (en) 1980-01-31
IL58526A true IL58526A (en) 1983-05-15

Family

ID=21822707

Family Applications (1)

Application Number Title Priority Date Filing Date
IL58526A IL58526A (en) 1979-03-28 1979-10-22 24,24-difluoro-1alpha,25-dihydroxycholecalciferol and pharmaceutical compositions containing it

Country Status (15)

Country Link
US (1) US4201881A (OSRAM)
JP (2) JPS6342618B2 (OSRAM)
AU (1) AU530015B2 (OSRAM)
BE (1) BE882143A (OSRAM)
CH (1) CH650240A5 (OSRAM)
DK (1) DK147300C (OSRAM)
FR (1) FR2452481A1 (OSRAM)
GB (2) GB2067567B (OSRAM)
IE (1) IE49753B1 (OSRAM)
IL (1) IL58526A (OSRAM)
IT (1) IT1140776B (OSRAM)
NL (1) NL7920190A (OSRAM)
NZ (1) NZ191900A (OSRAM)
SE (1) SE8008339L (OSRAM)
WO (1) WO1980002028A1 (OSRAM)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4284577A (en) * 1979-02-16 1981-08-18 Sachiko Yamada Novel vitamin D3 derivative and process for preparing the same
NZ201702A (en) * 1981-08-28 1985-08-16 Hoffmann La Roche 1 alpha,25-dihydroxy-(24r or 24s)-fluorocholecal-ciferol and intermediates;pharmaceutical compositions
NZ204223A (en) * 1982-05-17 1986-11-12 Hoffmann La Roche Veterinary compositions containing 24,24-difluoro-1 alpha,25-dihydroxycholecalciferol
US4456689A (en) * 1982-05-17 1984-06-26 Becton Dickinson And Company Competitive protein binding assay using an organosilane-silica gel separation medium
US4428946A (en) * 1982-07-26 1984-01-31 Wisconsin Alumni Research Foundation Method of preventing milk fever in dairy cattle
ATE45347T1 (de) * 1985-05-30 1989-08-15 Taisho Pharmaceutical Co Ltd Vitamin d3-derivate.
EP0245524B1 (en) * 1985-11-21 1991-04-17 Taisho Pharmaceutical Co. Ltd Vitamin d 3 derivative
US4853378A (en) * 1986-10-20 1989-08-01 Sumitomo Chemical Company, Limited Fluorine derivatives of vitamin D3 and process for producing the same
US5366736A (en) * 1989-02-16 1994-11-22 University Of Georgia Research Foundation, Inc. Vitamin D derivative feed compositions and methods of use
WO1990009179A1 (en) * 1989-02-16 1990-08-23 University Of Georgia Research Foundation, Inc. Treatment of tibial dyschondroplasia
US5316770A (en) * 1989-02-16 1994-05-31 University Of Georgia Research Foundation, Inc. Vitamin D derivative feed compositions and methods of use
US5063234A (en) * 1990-05-25 1991-11-05 Eli Lilly And Company Method of inhibiting demineralization of bone
MX2010007266A (es) * 2007-12-28 2010-11-30 Wisconsin Alumni Res Found Análogos de vitamina d, (20s)-23, 23-difluoro-2-metilen-19-nor-bis homopregnacalciferol.
JP5504898B2 (ja) * 2010-01-08 2014-05-28 セントラル硝子株式会社 ジフルオロシクロプロパン化合物の製造方法
GB202016614D0 (en) 2020-10-20 2020-12-02 King S College London Compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3741996A (en) * 1971-12-02 1973-06-26 Wisconsin Alumni Res Found 1{60 -hydroxycholecalciferol
US3969700A (en) * 1974-04-10 1976-07-13 International Business Machines Corporation Regional context maximum likelihood error correction for OCR, keyboard, and the like
FR2267590B1 (OSRAM) * 1974-04-10 1977-05-20 Ibm
JPS5729745B2 (OSRAM) * 1974-09-25 1982-06-24
US3993675A (en) * 1975-02-24 1976-11-23 Hoffmann-La Roche Inc. Process for the preparation of 1α,25-dihydroxycholecalciferol
US4069321A (en) * 1975-10-14 1978-01-17 Merck & Co., Inc. Blocked cholecalciferol and dihydrotachysterol 3 derivatives
US4284577A (en) * 1979-02-16 1981-08-18 Sachiko Yamada Novel vitamin D3 derivative and process for preparing the same

Also Published As

Publication number Publication date
FR2452481A1 (fr) 1980-10-24
NZ191900A (en) 1984-11-09
BE882143A (fr) 1980-07-01
AU530015B2 (en) 1983-06-30
CH650240A5 (de) 1985-07-15
SE8008339L (sv) 1980-11-27
AU5581080A (en) 1980-10-02
IT8020508A0 (it) 1980-03-11
GB2045765B (en) 1983-06-15
US4201881A (en) 1980-05-06
JPH0146504B2 (OSRAM) 1989-10-09
JPS56500296A (OSRAM) 1981-03-12
IE800619L (en) 1980-09-28
JPS63179855A (ja) 1988-07-23
GB2067567A (en) 1981-07-30
DK505080A (da) 1980-11-27
WO1980002028A1 (en) 1980-10-02
GB2045765A (en) 1980-11-05
DK147300B (da) 1984-06-12
IT1140776B (it) 1986-10-10
NL7920190A (nl) 1981-01-30
IL58526A0 (en) 1980-01-31
FR2452481B1 (OSRAM) 1984-10-19
GB2067567B (en) 1983-03-02
JPS6342618B2 (OSRAM) 1988-08-24
IE49753B1 (en) 1985-12-11
DK147300C (da) 1984-12-24

Similar Documents

Publication Publication Date Title
IL58123A0 (en) 4,5-diaryl-2-nitroimidazoles their preparation and pharmaceutical compositions containing them
DE3069944D1 (en) Chloro- and alkoxy-substituted-2,4-diaminoquinazolines and pharmaceutical compositions containing them
IL61376A (en) Trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives and pharmaceutical compositions containing them
NZ192400A (en) 5-methylisoxazole-4-carboxylic acid-4-trifluoromethyl-anilide and pharmaceutical compositions containing it
NZ190299A (en) 1,2,4-trizole -3,5- diamines and pharmaceutical compositions
NZ190745A (en) Mercapto-substituted -2,3,4,5-tetrahydro-1h-3-benzazepines and pharmaceutical compositions
IL60800A (en) 5-substituted-2,3-diarylthiophenes,their preparation and pharmaceutical compositions containing them
IL61930A (en) 25-hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol and pharmaceutical compositions containing it
IL58526A (en) 24,24-difluoro-1alpha,25-dihydroxycholecalciferol and pharmaceutical compositions containing it
IL63368A0 (en) 4,5-diaryl-alpha-polyfluoroalkyl-1h-imidazole-2-methanamines,their preparation and pharmaceutical compositions containing them
DE3069074D1 (en) 6-alpha-9-alpha-difluoro-16-beta-methyl-prednisolone-17,21 diesters and pharmaceutical compositions containing them
IL58478A0 (en) Pharmaceutical composition containing 3,4-dihydro-3-oxo-2-quinoxalines
GB2061306B (en) 1,3-glucanpolyol its preparation and composition comprising it
IL61117A0 (en) Acetoxymethyl-penem compounds and pharmaceutical compositions containing them
IL60376A (en) 3-diphenylmethyleneazetidines and pharmaceutical compositions containing them
IL64563A0 (en) 3,4-bis-substituted 1,2,5-oxidiazole 2-oxides,their preparation and pharmaceutical compositions containing them
NZ189881A (en) 4,5-diaryl-2-(substituted-thio)-pyrroles and pharmaceutical compositions
IL64252A (en) 3,3-dimethyl-indolin-2-ones,their preparation and pharmaceutical compositions containing them
IL54358A (en) 1-substituted-3-amino-6,7-dialkoxy-1h-1,2,4-benzothiadiazine-1-oxides,their preparation and pharmaceutical compositions containing them
NZ185539A (en) Cis-4a-aryl-2-substituted-2,3,4,4a,5,6,7,7a-octa hydro-1h-2-pyrindines and pharmaceutical compositions
IL60700A0 (en) 25-halocholest-5-ene-2 ,22-diols and esters thereof and pharmaceutical compositions containing them
IL59177A0 (en) Spiro-quinolylhydantoins and pharmaceutical compositions containing them
NZ184185A (en) 3,5,5-trimethylhexanoyl-ferrocene and pharmaceutical compositions
NZ189279A (en) Arylaminoimidazolines and pharmaceutical compositions
IL57882A (en) 2-thiophenecarboxamido-alkyl-mercaptans and pharmaceutical compositions containing them